Clinical Trial

Liquid Biospy for Urinary Cancers

Study acronym: CIRCE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 7, 2023 (before its estimated September 29, 2025 completion). Its status may not reflect the trial's current state.
Summary
The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-30.
Trial Details
NCT Number NCT06116396
Lead Sponsor IRCCS San Raffaele
Conditions Urothelial Carcinoma
Enrollment 450 participants
Start Date 2020-09-29
Primary Completion 2025-09-29 (estimated)
Study Completion 2028-09-29 (estimated)
Updated on ClinicalTrials.gov 2023-11-07